Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 12, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Exhibit at the 25th Annual World Congress on Anti-Aging Medicine in Las Vegas, NV - December 14-16th, 2017

LAS VEGAS, Dec. 12, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that it will be exhibiting at the 25th Annual World...
December 05, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Repays Installment Obligation on Convertible Debt

LAS VEGAS, Dec. 05, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) announced today that it has paid the December 2017 installment obligation...
November 21, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017

LAS VEGAS, Nov. 21, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017 Company enters its 3rd year exhibiting its...
November 14, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Named One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™

LAS VEGAS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty...
November 08, 2017 10:00 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Reports Third Quarter 2017 Financial Results

- Record Quarter for all Financial Performance Metrics - Management to Host Webcast on November 8, 2017 to Discuss Q3 2017 Operating Results LAS VEGAS, Nov. 08, 2017 (GLOBE NEWSWIRE) -- CV...
November 01, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Host Third Quarter 2017 Financial Results Conference Call on Wednesday, November 8, 2017

LAS VEGAS, Nov. 01, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc., (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived cannabidiol (CBD) oil...
October 17, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Repays Convertible Debt

LAS VEGAS, Oct. 17, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”), market-leading supplier and manufacturer of hemp-derived cannabidiol (CBD)...
October 10, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. to Exhibit at the 2017 Academy of Integrative Health & Medicine Annual Conference in San Diego, CA - October 22-25, 2017

LAS VEGAS, Oct. 10, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), today announced that its industry-dominating brand of hemp-derived...
October 03, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Announces its Platinum Sponsorship of Natural Products Association Expo Northwest in Portland, OR - October 13-14, 2017

LAS VEGAS, Oct. 03, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCBB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announces that its industry...
September 26, 2017 08:45 ET | Source: CV Sciences, Inc.

CV Sciences, Inc. Comments on Latest Research Citing Cannabidiol in Reducing the Risk of Post-Traumatic Stress Disorder

LAS VEGAS, Sept. 26, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we") is pleased to highlight yet another study identifying additional...